proDERM GmbH   Report issue

For profit Phase 2
Founded: Schenefeld Germany (1994)

Organization Overview

First Clinical Trial
2011
NCT01462643
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

proDERM GmbH | proDERM Institut für Angewandte Dermatologische Forschung GmbH

Active Ingredients

Drugs in Phase 2 Trials (2)

lactic acid (1 trial)

las41004 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2